Results 31 to 40 of about 6,579 (265)

Angiotensin-Converting Enzyme Inhibitor Protects Against Cisplatin Nephrotoxicity by Modulating Kinin B1 Receptor Expression and Aminopeptidase P Activity in Mice

open access: yesFrontiers in Molecular Biosciences, 2020
Cisplatin is a highly effective chemotherapeutic agent. However, its use is limited by nephrotoxicity. Enalapril is an angiotensin I-converting enzyme inhibitor used for the treatment of hypertension, mainly through the reduction of angiotensin II ...
Gabriel R. Estrela   +16 more
doaj   +1 more source

A New Radioimmunoassay for Kinins and It's Application for the Measurement of Urinary Kinins and Kallikrein Activity [PDF]

open access: yes, 1981
By using anti-synthetic bradykinin (BK) antibody in combination with 125I-tyrosyl-bradykinin, a sensitive and specific radioimmunoassay method for urinary kinins has been developed, and a simplified assay system for the measurement of urinary kallikrein ...
田中, 繁道, 島本, 和明
core   +1 more source

Kinin Receptor Antagonists as Potential Neuroprotective Agents in Central Nervous System Injury

open access: yesMolecules, 2010
Injury to the central nervous system initiates complex physiological, cellular and molecular processes that can result in neuronal cell death. Of interest to this review is the activation of the kinin family of neuropeptides, in particular bradykinin and
Anna V Leonard   +3 more
doaj   +1 more source

Kinins: Locally formed peptides during inflammation with potential use in tissue regeneration

open access: yes, 2023
Kinins are a set of peptides present in tissues and involved in cardiovascular regulation, inflammation, and pain.
Pesquero, J.B., Martins, L., Bader, M.
core   +1 more source

Evidence for the presence of a kininogen-like species in a case of total deficiency of low and high molecular weight kininogens

open access: yesBrazilian Journal of Medical and Biological Research, 1998
Low and high molecular weight kininogens (LK and HK), containing 409 and 626 amino acids with masses of ~65 and 120 kDa after glycosylation, respectively, are coded by a single gene mapped to the human chromosome 3 by alternative splicing of the ...
D. Veloso
doaj   +1 more source

Deletion of Kinin B2 Receptor Alters Muscle Metabolism and Exercise Performance. [PDF]

open access: yesPLoS ONE, 2015
Metabolic syndrome is a cluster of metabolic risk factors such as obesity, diabetes and cardiovascular diseases. Mitochondria is the main site of ATP production and its dysfunction leads to decreased oxidative phosphorylation, resulting in lipid ...
Felipe C G Reis   +14 more
doaj   +1 more source

Bradykinin receptor deficiency or antagonism do not impact the host response during gram-negative pneumonia-derived sepsis

open access: yesIntensive Care Medicine Experimental, 2019
Background Kinins are short peptides with a wide range of proinflammatory properties that are generated from kininogens in the so-called kallikrein-kinin system.
Chao Ding   +3 more
doaj   +1 more source

EVIDENCE FOR RENAL KININS AS MEDIATORS OF AMINO-ACID INDUCED HYPERPERFUSION AND HYPERFILTRATION IN THE RAT [PDF]

open access: yes, 1992
This study examined the role of tissue kallikrein and kinins in renal vasodilation produced by infusion of amino acids (AA). In rats fed a 9% protein diet for 2 wk, intravenous infusion of a 10% AA solution over 60-90 min reduced total renal vascular ...
SILVA, RH   +6 more
core   +2 more sources

Kallikrein/K1, Kinins, and ACE/Kininase II in Homeostasis and in Disease Insight From Human and Experimental Genetic Studies, Therapeutic Implication

open access: yesFrontiers in Medicine, 2019
Kallikrein-K1 is the main kinin-forming enzyme in organs in resting condition and in several pathological situations whereas angiotensin I-converting enzyme/kininase II (ACE) is the main kinin-inactivating enzyme in the circulation.
Francois Alhenc-Gelas   +6 more
doaj   +1 more source

Sensitive mass spectrometric determination of kinin-kallikrein system peptides in light of COVID-19

open access: yesScientific Reports, 2021
The outbreak of COVID-19 has raised interest in the kinin–kallikrein system. Viral blockade of the angiotensin-converting enzyme 2 impedes degradation of the active kinin des-Arg(9)-bradykinin, which thus increasingly activates bradykinin receptors known
Tanja Gangnus, Bjoern B. Burckhardt
doaj   +1 more source

Home - About - Disclaimer - Privacy